Akèy › Kansè Metastatik › Ohio › Akron
Etid klinik pou Kansè Metastatik nan Akron, OH
8 etid pou Kansè Metastatik ap chèche patisipan nan sit nan ak bò kote Akron (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Ap rekriteFaz 2
- Aultman Health Foundation, Canton · 21 mi lwen
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Ap rekriteFaz 3
- Aultman North, North Canton · 15 mi lwen
- Aultman Massillon, Massillon · 20 mi lwen
- Aultman Orrville Hospital, Orrville · 21 mi lwen
- ak 2 plis
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
Ap rekriteFaz 2
- Gabrail Cancer Center, Canton · 21 mi lwen
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Ap rekriteFaz 3
- Cleveland Clinic Akron General, Akron
- Gabrail Cancer Center, Canton · 21 mi lwen
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Ap rekriteFaz 3
- Gabrail Cancer & Research Center, Canton · 21 mi lwen
Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
Ap rekriteFaz 2/3
- Gabrail Cancer Center Research LLC, Canton · 21 mi lwen
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
Ap rekriteFaz 1/2
- Gabrail Cancer Research Center, Canton · 21 mi lwen
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
Ap rekriteFaz 1
- Gabrail Cancer & Research Center, Canton · 21 mi lwen
Etid Kansè Metastatik nan lòt vil
- Houston, TX104 etid
- New York City, NY93 etid
- Nashville, TN70 etid
- Boston, MA63 etid
- Los Angeles, CA57 etid
- St. Louis, MO54 etid
- Arlington, VA53 etid
- Philadelphia, PA46 etid
- Chicago, IL45 etid
- San Antonio, TX44 etid
- Washington, DC43 etid
- Dallas, TX42 etid
Lòt etid nan Akron
- Kansè Poumon ki pa ti selil22 etid
- Kansè poumon16 etid
- Kansè (tout kalite)13 etid
- Kansè nan tete13 etid
- Kansè pwostat9 etid
- Leksemi mieloïd egi8 etid
- Melanom8 etid
- Kansè poumon selil ti8 etid
- Kansè kolorektal8 etid
- Maladi fwa steatotik7 etid
- Kansè Endomèt6 etid
- Kansè ovè6 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.